$300 | Single User
$600 | Site License
$900 | Global License

JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

Published by Global Data: 09 Mar 2018 | 196851 | In Stock

Introduction

Summary

JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agents, contact lens care and ophthalmic agents, antifungal agents, cardiovascular agents, and gastrointestinla agents. JW Pharmaceutical also offers topicals, amino acid solutions, flexible IV container, IV solutions, respiratory agents, obgy agents, nephrology agents, CNS, urology agents and diabetic agents. The company offers products for cardiovascular, gastrointestinal, nephrology or antianaemic, anticancer and neuropsychiatry. JW Pharmaceutical is headquartered in Seoul, South Korea.

This comprehensive SWOT profile of JW Pharmaceutical Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of JW Pharmaceutical Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

  • Table of Contents

    Section 1 - About the Company

    JW Pharmaceutical Corp - Key Information

    JW Pharmaceutical Corp - Overview

    JW Pharmaceutical Corp - Key Employees

    JW Pharmaceutical Corp - Key Employee Biographies

    JW Pharmaceutical Corp - Key Operational Heads

    JW Pharmaceutical Corp - Major Products and Services

    JW Pharmaceutical Corp - History

    JW Pharmaceutical Corp - Company Statement

    JW Pharmaceutical Corp - Locations And Subsidiaries

    JW Pharmaceutical Corp - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    JW Pharmaceutical Corp - Business Description

    JW Pharmaceutical Corp - Corporate Strategy

    JW Pharmaceutical Corp - SWOT Analysis

    SWOT Analysis - Overview

    JW Pharmaceutical Corp - Strengths

    JW Pharmaceutical Corp - Weaknesses

    JW Pharmaceutical Corp - Opportunities

    JW Pharmaceutical Corp - Threats

    JW Pharmaceutical Corp - Key Competitors

    Section 3 - Company Financial Performance Charts

    JW Pharmaceutical Corp - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Tables


JW Pharmaceutical Corp, Key Information

JW Pharmaceutical Corp, Key Ratios

JW Pharmaceutical Corp, Share Data

JW Pharmaceutical Corp, Major Products and Services

JW Pharmaceutical Corp, History

JW Pharmaceutical Corp, Key Employees

JW Pharmaceutical Corp, Key Employee Biographies

JW Pharmaceutical Corp, Key Operational Heads

JW Pharmaceutical Corp, Other Locations

JW Pharmaceutical Corp, Subsidiaries

JW Pharmaceutical Corp, Key Manufacturing facilities

JW Pharmaceutical Corp, Key Competitors

JW Pharmaceutical Corp, SWOT Analysis

JW Pharmaceutical Corp, Ratios based on current share price

JW Pharmaceutical Corp, Annual Ratios

JW Pharmaceutical Corp, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Figures


JW Pharmaceutical Corp, Performance Chart

JW Pharmaceutical Corp, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

196851 | GDPH81871FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Sun Pharmaceutical 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Yabao Pharmaceutical Group Co., Ltd. (600351) - Financial and Strategic SWOT Analysis Review
SummaryYabao Pharmaceutical Group Co., Ltd. (Yabao Pharmaceutical) is a pharmaceutical company that ...
08 Nov 2015 by Global Data USD $300 More Info
Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic SWOT Analysis Review
SummaryWuyi International Pharmaceutical Company Limited (Wuyi International) is a pharmaceutical co...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Medical Equipment - Deals and Alliances Profile
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
23 Oct 2015 by Global Data USD $250 More Info
Otsuka Pharmaceutical Co., Ltd. - Medical Equipment - Deals and Alliances Profile
SummaryOtsuka Pharmaceutical Co., Ltd. (OPC) a subsidiary of Otsuka Holdings Co., Ltd. is a pharmace...
23 Oct 2015 by Global Data USD $250 More Info
Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Financial and Strategic SWOT Analysis Review
Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Financial and Strategic SWOT Analysis Review provi...
20 Oct 2015 by Global Data USD $125 More Info
Glide Pharmaceutical Technologies Limited - Medical Equipment - Deals and Alliances Profile
SummaryGlide Pharmaceutical Technologies Limited (Glide Pharma) is a specialty pharmaceutical develo...
16 Oct 2015 by Global Data USD $250 More Info
Collegium Pharmaceutical, Inc. (COLL) - Medical Equipment - Deals and Alliances Profile
SummaryCollegium Pharmaceutical, Inc. (Collegium) is a pharmaceutical company which develops proprie...
16 Oct 2015 by Global Data USD $250 More Info
Hisamitsu Pharmaceutical Co., Inc. (4530) - Medical Equipment - Deals and Alliances Profile
SummaryHisamitsu Pharmaceutical Co., Inc. (Hisamitsu Pharmaceutical) is a pharmaceutical company tha...
16 Oct 2015 by Global Data USD $250 More Info
Adapting to a New Environment: Emerging Segmentation Practice in the Pharmaceutical Industry
Introduction“If you’re not talking segmentation, then you’re not talking marketing.” While German-...
01 Feb 2012 by FirstWord Pharma USD $595 More Info

This report is published by Global Data

Download Free Report Summary PDF

JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data